CERULLO, VINCENZO
 Distribuzione geografica
Continente #
NA - Nord America 1.134
AS - Asia 666
EU - Europa 602
AF - Africa 22
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 1
Totale 2.434
Nazione #
US - Stati Uniti d'America 1.101
SG - Singapore 284
IT - Italia 266
HK - Hong Kong 179
CN - Cina 139
RU - Federazione Russa 75
NL - Olanda 65
FR - Francia 53
IN - India 44
FI - Finlandia 35
CA - Canada 30
DE - Germania 29
IE - Irlanda 22
CI - Costa d'Avorio 19
SE - Svezia 18
UA - Ucraina 15
VN - Vietnam 12
GB - Regno Unito 8
AT - Austria 6
BR - Brasile 5
CZ - Repubblica Ceca 3
CL - Cile 2
IL - Israele 2
KR - Corea 2
LT - Lituania 2
MA - Marocco 2
MX - Messico 2
PK - Pakistan 2
BE - Belgio 1
BO - Bolivia 1
DK - Danimarca 1
EU - Europa 1
IR - Iran 1
MD - Moldavia 1
MK - Macedonia 1
PA - Panama 1
SK - Slovacchia (Repubblica Slovacca) 1
UZ - Uzbekistan 1
VE - Venezuela 1
ZA - Sudafrica 1
Totale 2.434
Città #
Singapore 196
Hong Kong 179
Chandler 162
Santa Clara 132
Millbury 81
Naples 74
Amsterdam 60
Ashburn 46
Napoli 42
Boston 39
Delhi 38
Princeton 38
Nanjing 33
Des Moines 32
Lawrence 30
Ottawa 27
Seattle 23
Jacksonville 21
Wilmington 21
Nanchang 20
Beijing 15
Helsinki 13
Shanghai 13
Dong Ket 12
Shenyang 11
Hebei 10
Jiaxing 10
Dallas 8
Council Bluffs 7
Houston 7
Acerra 6
Kronberg 6
Rome 6
Lappeenranta 5
Nuremberg 5
Pune 5
Lissone 4
Moscow 4
Sesto Fiorentino 4
Boardman 3
Changsha 3
Fairfield 3
Milan 3
Munich 3
Portici 3
Tianjin 3
Toronto 3
Vienna 3
Woodbridge 3
Ann Arbor 2
Bologna 2
Brescia 2
Brindisi 2
Brno 2
Casablanca 2
Centro 2
Chuncheon 2
Dublin 2
Ercolano 2
Juiz de Fora 2
Mexico City 2
New York 2
Rashidabad 2
Redwood City 2
Rotondi 2
San Jose 2
San Paolo Bel Sito 2
Spoltore 2
Villarosa 2
Abbiategrasso 1
Arco 1
Atibaia 1
Bad Bellingen 1
Battipaglia 1
Bethesda 1
Boydton 1
Bratislava 1
Brussels 1
Capri 1
Casavatore 1
Catania 1
Cercola 1
Chengdu 1
Copenhagen 1
Extrema 1
Falkenstein 1
Florence 1
Harbin 1
Hefei 1
Indiana 1
Jinan 1
Johannesburg 1
Krefeld 1
La Paz 1
Leawood 1
Loreto 1
Los Angeles 1
Luohe 1
Manassas 1
Maturín 1
Totale 1.546
Nome #
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma 141
Oncolytic adenovirus loaded with L-carnosine as novel strategy to enhance the antitumor activity 77
Peptide Nucleic Acid-Functionalized Adenoviral Vectors Targeting G-Quadruplexes in the P1 Promoter of Bcl-2 Proto-Oncogene: A New Tool for Gene Modulation in Anticancer Therapy 69
Oncolytic adenovirus loaded with L-carnosine as a drug delivery system for cancer therapy. 63
Ischemic Neoangiogenesis Enhanced by {beta}2-Adrenergic Receptor Overexpression. A Novel Role for the Endothelial Adrenergic System. 62
Discovery of a novel one-step RuO4-catalysed tandem oxidative polycyclization/ double spiroketalization process. Access to a new type of polyether bis-spiroketal compound displaying antitumour activity 61
Helper-dependent adenovirus-mediated gene transfer of a secreted LDL receptor/transferrin chimeric protein reduces aortic atherosclerosis in LDL receptor-deficient mice 55
Synthesis and Evaluation of the Antiproliferative Properties of a Tethered Tubercidin-Platinum(II) Complex 52
Antitumor-specific T-cell responses induced by oncolytic adenovirus ONCOS-102 (AdV5/3-D24-GM-CSF) in peritoneal mesothelioma mouse model 50
Oncolytic Adenoviral Vector-Mediated Expression of an Anti-PD-L1-scFv Improves Anti-Tumoral Efficacy in a Melanoma Mouse Model 45
PEGylated helper-dependent adenoviral vector expressing human Apo A-I for gene therapy in LDLR-deficient mice 45
Synergistic anti-tumor efficacy of immunogenic adenovirus ONCOS-102 (Ad5/3-D24-GM-CSF) and standard of care chemotherapy in preclinical mesothelioma model 42
Oncolytic vaccines increase the response to PD-L1 blockade in immunogenic and poorly immunogenic tumors 41
Evaluation of the antiproliferative effect of Bifidobacterium longum BB-536 in solid tumor cell lines, co-cultured with murine splenocytes 41
Exploring the DNA2-PNA heterotriplex formation in targeting the Bcl-2 gene promoter: A structural insight by physico-chemical and microsecond-scale MD investigation 40
AKT participates in endothelial dysfunction in hypertension. 40
Discovery of a novel one-step RuO4-catalysed tandem oxidative polycyclization/double spiroketalization process. Access to a new type of polyether bis-spiroketal compound displaying antitumor activity 40
Application of array-comparative genomic hybridization analysis in immune-virotherapy approach 39
Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors 38
Personalized Cancer Vaccine Platform for Clinically Relevant Oncolytic Enveloped Viruses 37
Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor 37
Bioengineered Factor IX Molecules with Increased Catalytic Activity Improve the Therapeutic Index of Gene Therapy Vectors for Hemophilia B. 36
Oncolytic adenovirus coding for granulocyte macrophage colony-stimulating factor induces antitumoral immunity in cancer patients 36
Systems Biology Approaches for the Improvement of Oncolytic Virus-Based Immunotherapies 36
Oncolytic adenoviruses coated with MHC-I tumor epitopes increase the antitumor immunity and efficacy against melanoma 35
Oncolytic adenoviruses for cancer therapy 34
PEGylated Helper-Dependent Adenoviral Vectors: Highly Efficient Vectors with an Enhanced Safety Profile 34
Synthesis and biological evaluation of unprecedented ring-expanded nucleosides (RENs) containing the imidazo[4,5-d][1,2,6]oxadiazepine ring system. 34
Discovery of a new PCC-mediated stereoselective oxidative spiroketalization process. An access to a new type of poly-THF spiroketal compound displaying anticancer activity 33
Serotype chimeric and fiber-mutated adenovirus Ad5/19p-HIT for targeting renal cancer and untargeting the liver 33
Artificially cloaked viral nanovaccine for cancer immunotherapy 33
Generation of a helper-dependent adenoviral vector by homologous recombination 32
The evolution of adenoviral vectors through genetic and chemical surface modifications 32
Defects in innate immunity render breast cancer initiating cells permissive to oncolytic adenovirus 31
Viral molecular mimicry influences the antitumor immune response in murine and human melanoma 31
Expression of DAI by an oncolytic vaccinia virus boosts the immunogenicity of the virus and enhances antitumor immunity 30
Armed oncolytic virus enhances immune functions of chimeric antigen receptor-modified T cells in solid tumors 30
Chronic activation of innate immunity correlates with poor prognosis in cancer patients treated with oncolytic adenovirus 30
Solid phase synthesis of new dinuclear platinum complexes having a modified nucleoside as ligand. 29
A novel immunopeptidomic-based pipeline for the generation of personalized oncolytic cancer vaccines 29
PeptiCHIP: A Microfluidic Platform for Tumor Antigen Landscape Identification 29
Tumor suppressor role of hsa-mir-193a-3p and-5p in cutaneous melanoma 27
Design and application of oncolytic viruses for cancer immunotherapy 27
Exploiting preexisting immunity to enhance oncolytic cancer immunotherapy 27
Toll-like Receptor 9 Triggers an Innate Immune Response to Helper-dependent Adenoviral Vectors. 24
Antiviral and antitumor T-cell immunity in patients treated with GM-CSF-coding oncolytic adenovirus 24
Combinatorial treatment with oncolytic adenovirus and helper-dependent adenovirus augments adenoviral cancer gene therapy 24
Oncolytic adenovirus drives specific immune response generated by a poly-epitope pDNA vaccine encoding melanoma neoantigens into the tumor site 24
Uncovering the tumor antigen landscape: What to know about the discovery process 24
CD40 ligand and tdTomato-armed vaccinia virus for induction of antitumor immune response and tumor imaging 23
Bifidobacterium affects antitumor efficacy of oncolytic adenovirus in a mouse model of melanoma 22
Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans 22
Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy 21
Circulating microRNAs as biomarkers for early diagnosis of cutaneous melanoma 21
Therapeutic cancer vaccination with immunopeptidomics-discovered antigens confers protective antitumor efficacy 21
Thiol-ene surface modifications for microchip electrophoresis based interaction assays 20
Engineering an oncolytic adenoviral platform for precise delivery of antisense peptide nucleic acid to modulate PD-L1 overexpression in cancer cells 20
Short-Term Correction of Arginase Deficiency in a Neonatal Murine Model with a Helper-Dependent Adenoviral Vector. 20
An oncolytic adenovirus enhanced for toll-like receptor 9 stimulation increases antitumor immune responses and tumor clearance 20
Immunological Effects of a Tumor Necrosis Factor Alpha-Armed Oncolytic Adenovirus 20
Extracellular vesicles enhance the targeted delivery of immunogenic oncolytic adenovirus and paclitaxel in immunocompetent mice 20
Dual-peptide functionalized acetalated dextran-based nanoparticles for sequential targeting of macrophages during myocardial infarction 20
Harnessing therapeutic viruses as a delivery vehicle for RNA-based therapy 20
A novel in silico framework to improve MHC-I epitopes and break the tolerance to melanoma (vol 6, e1319028, 2017) 19
Immunological effects of low-dose cyclophosphamide in cancer patients treated with oncolytic adenovirus 19
PeptiVAX: A new adaptable peptides-delivery platform for development of CTL-based, SARS-CoV-2 vaccines 18
MyD88-dependent silencing of transgene expression during the innate and adaptive immune response to Helper-dependent adenovirus. 18
Characterization of a novel OX40 ligand and CD40 ligand-expressing oncolytic adenovirus used in the PeptiCRAd cancer vaccine platform 18
GMCSF-armed vaccinia virus induces an antitumor immune response 17
Novel personalized cancer vaccine platform based on Bacillus Calmette-Guèrin 17
Novel oncolytic adenovirus expressing enhanced cross-hybrid IgGA Fc PD-L1 inhibitor activates multiple immune effector populations leading to enhanced tumor killing in vitro, in vivo and with patient-derived tumor organoids 17
Immune response is an important aspect of the antitumor effect produced by a CD40L-encoding oncolytic adenovirus 16
Fc-gamma receptor polymorphisms as predictive and prognostic factors in patients receiving oncolytic adenovirus treatment 15
GAMER-Ad: a novel and rapid method for generating recombinant adenoviruses 15
Oncolytic immunotherapy of advanced solid tumors with a CD40L-expressing replicating adenovirus: Assessment of safety and immunologic responses in patients 14
Extracellular vesicles provide a capsid-free vector for oncolytic adenoviral DNA delivery 14
Oncolytic adenovirus with temozolomide induces autophagy and antitumor immune responses in cancer patients 13
NOD2 signaling contributes to the innate immune response against helper-dependent adenovirus vectors independently of MyD88 in vivo 13
Pathogens: Our Allies against Cancer? 12
PNA-functionalized adenoviral vectors as new tool for gene modulation in anti-cancer treatment 11
Optimization of Early Steps in Oncolytic Adenovirus ONCOS-401 Production in T-175 and HYPERFlasks 9
Novel peptide-based oncolytic vaccine for enhancement of adaptive antitumor immune response via co-engagement of innate Fcγ and Fcα receptors 8
Influence of Cell Membrane Wrapping on the Cell−Porous Silicon Nanoparticle Interactions 8
Low-dose Decitabine enhances the efficacy of viral cancer vaccines for immunotherapy 8
Selenium Nanoparticles Synergize with a KRAS Nanovaccine against Breast Cancer 5
Development of mesothelioma-specific oncolytic immunotherapy enabled by immunopeptidomics of murine and human mesothelioma tumors 3
Totale 2.560
Categoria #
all - tutte 13.254
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.254


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202044 0 0 0 0 0 0 0 0 0 5 23 16
2020/2021132 5 2 36 3 6 12 5 20 13 5 9 16
2021/2022348 6 0 0 7 1 11 3 12 48 11 78 171
2022/2023486 71 47 11 20 50 44 1 54 71 70 25 22
2023/2024407 31 76 52 19 15 36 19 58 3 4 61 33
2024/2025830 135 122 10 15 66 122 247 113 0 0 0 0
Totale 2.560